Benorylate: A Report on 2 Years' Experience of Its Use in Rheumatoid Arthritis and Other Chronic Rheumatic Diseases
- 1 January 1976
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 4 (sup13) , 29-32
- https://doi.org/10.3109/03009747609095641
Abstract
52 outpatients with rheumatoid arthritis or osteoarthritis were given benorylate (as the 40% suspension) in doses of up to 8 g daily. Periods of medication were varied but some patients were given the drug for nearly 2 years. Assessments of clinical progress were made at regular intervals by recording both subjective and objective measurements including duration of morning stiffness, grip strength, joint size. Laboratory investigations include renal function tests, liver function tests, blood picture and occult blood. No serious side effect, attributable to benorylate was reported and it was concluded that the drug is satisfactory for the long term treatment of rheumatic diseases.Keywords
This publication has 0 references indexed in Scilit: